UNSPSC 51202901: Abetimus

This classification denotes an immunosuppressant, a biological preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) F5Y7739G6U. World Health Organization schedules abetimus in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule abetimus under HS 29349990 and SITC 51579. As of Q4 2014, ABETIMUS remains US FDA's Preferred Term for this commodity.

For the most current information on WCO designations on abetimus and salts thereof, please see Committee proceedings HSC/53, NC2004B1b Ann. O/6 (2014).

UNSPSC 51202901 Abetimus, a Commodity code, encompasses pharmaceutical products and medical supplies that state and local governments procure for emergency response, public health, and employee health programs. The recent solicitations under this code show state and local buyers purchasing naloxone and drug deactivation systems for community health initiatives, medical and first aid supplies for fire department rescue operations, generic pharmaceuticals and over-the-counter products through cooperative purchasing alliances, and direct-to-manufacturer prescription fulfillment capabilities. Issuing bodies include county health departments, municipal fire departments, state health and human services agencies, and state procurement offices administering multistate cooperative purchasing vehicles. The scope spans emergency medical consumables, pharmaceutical manufacturing and distribution through authorized wholesalers, and pharmacy benefit program innovation, with vendors required to demonstrate cGMP and Drug Supply Chain Security Act compliance, maintain appropriate insurance coverage, and meet strict delivery and expiration-date requirements.

Recent activity concentrates in Florida, Texas, Minnesota, and Oregon. The Seminole County, Florida IFB 60459723LAS (posted June 30, 2026) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a July 26, 2023 response deadline. The City of Tampa's ITB 26P00145 (posted March 25, 2026) solicited 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000.00 and a March 13, 2026 response deadline, designated as a sheltered market opportunity with a 5% bid discount for certified Small Local Business Enterprises. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (posted January 20, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with responses due March 26, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) seeking vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, signaling future formal procurement in that state.